Koninklijke Philips (PHG) Competitors

Koninklijke Philips logo
$29.88 -0.27 (-0.88%)
Closing price 11/17/2026 03:59 PM Eastern
Extended Trading
$29.82 -0.06 (-0.20%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PHG vs. BSX, BDX, EW, IDXX, and GEHC

Should you buy Koninklijke Philips stock or one of its competitors? Koninklijke Philips's main competitors and comparable companies include Boston Scientific (BSX), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), and GE HealthCare Technologies (GEHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Koninklijke Philips compare to Boston Scientific?

Koninklijke Philips (NYSE:PHG) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Boston Scientific has lower revenue, but higher earnings than Koninklijke Philips. Boston Scientific is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.46$1.01B$1.1725.53
Boston Scientific$20.07B3.11$2.90B$2.3618.24

Boston Scientific has a net margin of 16.62% compared to Koninklijke Philips' net margin of 5.40%. Boston Scientific's return on equity of 18.61% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips5.40% 14.86% 6.20%
Boston Scientific 16.62%18.61%10.58%

In the previous week, Boston Scientific had 10 more articles in the media than Koninklijke Philips. MarketBeat recorded 13 mentions for Boston Scientific and 3 mentions for Koninklijke Philips. Boston Scientific's average media sentiment score of 0.65 beat Koninklijke Philips' score of -0.02 indicating that Boston Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Boston Scientific
5 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Boston Scientific has a consensus target price of $61.43, indicating a potential upside of 42.68%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Boston Scientific
2 Sell rating(s)
8 Hold rating(s)
20 Buy rating(s)
1 Strong Buy rating(s)
2.65

Koninklijke Philips has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Boston Scientific beats Koninklijke Philips on 15 of the 17 factors compared between the two stocks.

How does Koninklijke Philips compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 1.9%. Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 2.8%. Becton, Dickinson and Company pays out 101.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend. Becton, Dickinson and Company has increased its dividend for 53 consecutive years. Koninklijke Philips is clearly the better dividend stock, given its higher yield and lower payout ratio.

Becton, Dickinson and Company has a beta of 0.22, suggesting that its stock price is 78% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Becton, Dickinson and Company presently has a consensus target price of $197.47, indicating a potential downside of 8.48%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.50
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Becton, Dickinson and Company has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$19.46B3.06$1.15B$4.1452.12
Koninklijke Philips$20.17B1.46$1.01B$1.1725.53

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Becton, Dickinson and Company had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 6 mentions for Becton, Dickinson and Company and 3 mentions for Koninklijke Philips. Becton, Dickinson and Company's average media sentiment score of 0.97 beat Koninklijke Philips' score of -0.02 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Becton, Dickinson and Company has a net margin of 5.66% compared to Koninklijke Philips' net margin of 5.40%. Becton, Dickinson and Company's return on equity of 14.90% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company5.66% 14.90% 7.09%
Koninklijke Philips 5.40%14.86%6.20%

Summary

Becton, Dickinson and Company beats Koninklijke Philips on 16 of the 20 factors compared between the two stocks.

How does Koninklijke Philips compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

In the previous week, Edwards Lifesciences had 16 more articles in the media than Koninklijke Philips. MarketBeat recorded 19 mentions for Edwards Lifesciences and 3 mentions for Koninklijke Philips. Edwards Lifesciences' average media sentiment score of 0.73 beat Koninklijke Philips' score of -0.02 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
9 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Edwards Lifesciences has a net margin of 15.30% compared to Koninklijke Philips' net margin of 5.40%. Edwards Lifesciences' return on equity of 16.06% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences15.30% 16.06% 12.36%
Koninklijke Philips 5.40%14.86%6.20%

Edwards Lifesciences has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

Edwards Lifesciences presently has a consensus target price of $109.88, suggesting a potential upside of 4.38%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Edwards Lifesciences is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
0 Sell rating(s)
3 Hold rating(s)
23 Buy rating(s)
0 Strong Buy rating(s)
2.88
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Edwards Lifesciences has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$6.07B9.98$1.07B$1.7759.47
Koninklijke Philips$20.17B1.46$1.01B$1.1725.53

Summary

Edwards Lifesciences beats Koninklijke Philips on 15 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

IDEXX Laboratories has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDEXX Laboratories$4.30B12.64$1.06B$14.8346.54
Koninklijke Philips$20.17B1.46$1.01B$1.1725.53

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Koninklijke Philips had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 3 mentions for Koninklijke Philips and 2 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.42 beat Koninklijke Philips' score of -0.02 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEXX Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

IDEXX Laboratories presently has a consensus price target of $717.27, suggesting a potential upside of 3.92%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories
0 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.54
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

IDEXX Laboratories has a beta of 1.55, indicating that its stock price is 55% more volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

IDEXX Laboratories has a net margin of 25.36% compared to Koninklijke Philips' net margin of 5.40%. IDEXX Laboratories' return on equity of 71.04% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
IDEXX Laboratories25.36% 71.04% 33.99%
Koninklijke Philips 5.40%14.86%6.20%

Summary

IDEXX Laboratories beats Koninklijke Philips on 14 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to GE HealthCare Technologies?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.46$1.01B$1.1725.53
GE HealthCare Technologies$20.63B1.79$2.08B$4.7417.27

GE HealthCare Technologies has a consensus target price of $82.17, suggesting a potential upside of 0.41%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
0 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.52

In the previous week, GE HealthCare Technologies had 8 more articles in the media than Koninklijke Philips. MarketBeat recorded 11 mentions for GE HealthCare Technologies and 3 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.74 beat Koninklijke Philips' score of -0.02 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
GE HealthCare Technologies
2 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Koninklijke Philips has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market.

GE HealthCare Technologies has a net margin of 9.96% compared to Koninklijke Philips' net margin of 5.40%. GE HealthCare Technologies' return on equity of 20.45% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips5.40% 14.86% 6.20%
GE HealthCare Technologies 9.96%20.45%5.97%

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 2.8%. GE HealthCare Technologies pays an annual dividend of $0.16 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

Summary

GE HealthCare Technologies beats Koninklijke Philips on 16 of the 19 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PHG vs. The Competition

MetricKoninklijke PhilipsHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$29.62B$5.99B$7.83B$23.08B
Dividend Yield2.79%1.68%2.47%3.82%
P/E Ratio15.0737.4034.0025.99
Price / Sales1.465.398.483.25
Price / Cash9.7523.6221.0115.54
Price / Book2.204.174.463.65
Net Income$1.01B$143.92M$3.52B$1.07B
7 Day Performance-1.16%-5.49%-5.94%-4.19%
1 Month Performance16.04%-3.68%-4.59%-2.47%
1 Year Performance8.53%-0.11%-1.93%5.85%

Koninklijke Philips Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PHG
Koninklijke Philips
2.5153 of 5 stars
$29.88
-0.9%
N/A+6.6%$29.62B$20.17B15.0765,340
BSX
Boston Scientific
4.1592 of 5 stars
$44.00
+2.9%
$61.43
+39.6%
-57.7%$66.41B$20.07B18.6459,000
BDX
Becton, Dickinson and Company
4.1893 of 5 stars
$215.13
+1.5%
$195.47
-9.1%
+13.0%$57.64B$21.84B51.9672,000
EW
Edwards Lifesciences
2.9325 of 5 stars
$104.72
+2.5%
$108.88
+4.0%
+24.2%$57.22B$6.07B59.1616,000
IDXX
IDEXX Laboratories
2.4163 of 5 stars
$706.65
+4.5%
$717.27
+1.5%
+3.2%$55.04B$4.30B47.6511,000

Related Companies and Tools


This page (NYSE:PHG) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners